👨‍🔬 🔬 Have you read our latest #MedChemBioConversation ? Get to know Khaled Essa from Leiden University in the Netherlands 🔍 Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice. 🔗https://buff.ly/hCQFZ2v

📃 EFMC Literature Spotlight 📃 This month's contribution, provided by Dr Tiago Bozzola, discusses the recently published article “A Facile Protocol for C(sp²)–C(sp³) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands” by Maksutova et al. 👉 Read the full paper here: buff.ly/LG9rzh2

📰 The February MedChemBioWatch is out! Catch the latest updates, highlights, and upcoming events in one quick read. 🔗 buff.ly/0bkbiXE

Join us for an online workshop tackling impostor syndrome in research environments. The event features a keynote by Prof. Luis Echegoyen, followed by small-group discussion rooms designed for peer exchange. 📅 26 Feb | 💻️ Online 🔗 buff.ly/SmZ9KyQ Organised by EFMC-YSN & EYCN. Registration required

🎓 EFMC Honorary Fellowship - 2026 Call ✨ The fellowship acknowledges: scientific excellence, long-term commitment, and community service in academia and industry. 🔎 Details and nomination info: buff.ly/TusoH2o 📅 Deadline: 31st March 2026

🚀 New resource available for the Medicinal Chemistry community! A concise poster summarizing key best‑practice guidance in Medicinal Chemistry is now available. 🧪 Feel free to download, print, and share it in your lab 👉 Access the high‑definition poster here: buff.ly/FTjoQGu

🎉 Announcing the Novalix PhD Prize for Early Career Researchers! This prize honors outstanding doctoral work in MedChemBio. PhD candidates from Europe can win: 💰️ 1000€ 🗣️ a speaking slot at the EFMC Young Scientists Symposium ✈️ a 500€ travel grant ⏰️ Deadline is March 31 🔗 buff.ly/wKLW2X5

👨‍🔬 🔬 Have you read our latest #MedChemBioConversation ? Get to know Laszlo Petri from the HUN-REN Hungarian Research Centre for Natural Sciences, Hungary.🔍 🔗https://buff.ly/JCKweiX

🚀 Ready to level up your CV? Join us for an upcoming 90-minute online session where Dr Robert Bowles will showcase a CV-building workshop, and industry experts will share practical tips on how to tailor your CV and stand out in today’s competitive job market. 👉 Register here: buff.ly/yeu9ndy

📃 EFMC Literature Spotlight 📃 This edition’s contribution focuses on the article "Multidisciplinary Preclinical Investigations on Ferrocenyl, Ruthenocenyl, and Benzyl Derivatives of Niridazole as New Drug Candidates against Schistosomiasis" by Tanja Karpstein et al. 👉 buff.ly/xLYGUZi

📰 The first MedChemBioWatch issue of the year has just arrived! 📰 Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events. 🔗 buff.ly/m0cJQm3

🏆 EFMC Awards 2026 - Deadline is approaching 🏆 Each of the three awards includes: 📄 A diploma 💰 €7,500 🎤 Invitation to deliver a headline presentation at EFMC Medicinal Chemistry 2026 🔗 Apply here: buff.ly/Bcjtt6s ⏱️ Submission deadline: January 31, 2026

🔬 Have you read our latest #MedChemBioConversation? 👩 Get to know Anne Valade from UCB, Belgium!🧪 Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice. 🔗 Read the full interview here: buff.ly/9PMKV8m

🏆 EFMC Prizes 2026 🏆 📢 Deadline is approaching, January 31, 2026 👉 Apply here: buff.ly/fmVFoBa

As 2025 ends, we sincerely thank you for your trust and support of EFMC. Wishing you a joyful festive season and a prosperous New Year! Warm regards, Luc Van Hijfte (EFMC President) Gianluca Sbardella (EFMC President Elect)

📃 EFMC Literature Spotlight 📃 This contribution focuses on the article “Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen” by Berwanger et al. 📖 buff.ly/uV9xZ4h

📰 The December issue of MedChemBioWatch has just arrived! 📰 Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events. 🔗 buff.ly/x5bFcOd

🚀 Want to become a skilled peer reviewer? Join the EFMC Reviewer Academy, led by editors from Chemistry Europe / Wiley-VCH. ✅ Free online course ✅ Interactive workshop & Q&A (next session: Dec 15) ✅ Hands-on review assignment 👉 Apply now: buff.ly/WHa1PTD

🏆 EFMC Awards 2026 - Call for Nominations 🏆 To celebrate remarkable contributions in Medicinal Chemistry and Chemical Biology, the EFMC will confer three awards in 2026. ⏱️ January 31, 2026

📢 The 5th and final Lunch & Learn session is coming! Join us to explore Targeting RNA with Small Molecules" with 👨‍🔬🔬 Federico Riu (Italian Institute of Technology, IT), Elena Mencarelli and Kateryna Demchenko (Université Côte D'Azur, FR). 📅 Dec 9, 13:00 CET/12:00UK. 🔗https://buff.ly/P4eJkNK

Join us for the 7th EFMC² Tandem Talk to hear about P-site-binding TEAD inhibitors, including structure-based refinement and their mechanism of action. Our sponsor, Optibrium, will also discuss their advanced drug discovery tools. 📅 December 4 🔗 buff.ly/sacyw1W

🌟 The EFMC-Young Scientists Network is recruiting! 🌟 We’re looking for motivated early-career researchers to join us as Supporting Members and help shape the future of our community. 📅 Apply by December 16 🔗 buff.ly/Lh0x51d

🚨 Deadline Extented Unitl November 17th! 🚨 💊 Join us on November 20th for the 2025 MedChemBioPoster Online (#MCBPoster25)! 🧠 From 10 AM to 6 PM, share YOUR research on LinkedIn as a poster and compete to win prizes (up to 150 euros)! 🏆 👉 Register here: buff.ly/vY5o2Fk

Join Wiktor Szymanski, Nadja A. Simeth-Crespi, Johannes Broichhagen, and Jana Volaric for MedChemBioOnline on Photopharmacology. Discover innovative light-responsive compounds used in modulating biological functions. 📅 Nov. 25 🔗 buff.ly/umzJAAr

📃 EFMC Literature Spotlight 📃 This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al. 🔗 buff.ly/Glod3p1

👨🔬 Have you read our latest hashtag#MedChemBioConversation ? Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪 Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice. 🔗 buff.ly/70Fu4wv

📰 The November issue of MedChemBioWatch has arrived! 📰 Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events. 🔗 buff.ly/xazhYlo

📢 The next Publishing Academy edition is approaching! Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers. 📅 November 13 ⏰ Register by November 10 🔗 buff.ly/Wt7jvqE

⚠️ Less than 10 days to register ! ⚠️ On November 20th, MedChemBioPoster Online (#MCBPoster25) is back! 🏆 Prizes up to 150 euros ⏳ Deadline: November 13th 🔗 www.efmc.info/web/medchemb...

📃 EFMC Literature Spotlight 📃 This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)

Do not miss the 7th EFMC² Tandem Talks! Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation". 📅 Dec 4 - 4pm CET 🔗 buff.ly/eQnLJIm

👩🔬 Have you read our latest #MedChemBioConversation ? Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍 Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice. 🔗https://buff.ly/qayWsyu

Academia is tough — burnout, imposter syndrome, and the pressure to publish can be overwhelming. 💭 Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia. 🎙 Lashuel, Cahill & Ho 👉 Register: www.efmc.info/mental-healt...

Don't miss out on the EFMC² Tandem Talks where Hans Matter and Maria Méndez Pérez (Sanofi) will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitor. 📅 October 9 - 4 PM 🔗 buff.ly/1jaKQAQ

Join us for "Under Pressure: A Mental Health Conversation for the Academic Community," a virtual workshop to build resilience, support, and a healthier future in academia. 📅 October 10 - 1PM 🔗 buff.ly/CiXa7F8 Complete our anonymous survey to shape the discussion. 📝 buff.ly/H2NmBru

🖥️ MedChemBio Posters Online is coming back ! 📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry. ▶️ More info & Registration on: buff.ly/4j57fID

📃 EFMC Literature Spotlight 📃 This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)

👩‍🔬 Have you read our latest #MedChemBioConversation ? Get to know Gavriil Efthymios from Imperial College London, UK.🔍 Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice. 🔗https://buff.ly/JgcwZqf

📢 The 3rdnd Lunch & Learn session is coming! Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley. 📅 Oct 14, 13:00 CET. 🔗https://buff.ly/xpMDjcN #DrugDiscovery

📰The September issue of MedChemBioWatch has arrived!📰 Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.

The schedule is out! Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation. 📅 October 9 - 4pm 🔗 buff.ly/KINI5tx

Strong start to the final day of EFMC-ASMC 2025! Dr Jesus Alcazar (J&J) on flow automation for drug discovery, followed by inspiring work from Prof. Paula Gomes (University of Porto) on Nobel-prized chemistries for new therapies.

Kicking off the last day of EFMC-ASMC 2025!

Excellent talk this afternoon by Dr Rebecca Ebenhoch (Boehringer Ingelheim) on the power of cEM to enable structure-based drug design for membrane targets.

A new day of knowledge has officially begun with the first talk of the day: Dr Matthew Woll (PTC Therapeutics) on Therapeutic Splice Modifiers.

Great science this afternoon at EFMC-ASMC 2025! Dr Thomas Cummins (BMS) presented exciting work on a first-in-class molecular glue degrader for sickle cell disease, followed by Dr Emanuela Berrino (CEA Paris-Saclay) with excellent insights into fluorescent nanoparticles for multiplexed immunoassays.

A strong start to Day 2 of EFMC-ASMC 2025! Prof. Dirk Trauner (UPenn) opened the morning with excellent insights into photopharmacology, followed by essencial work from Dr Luke Ashcraft (Cytokinetics) on novel cardiac myosin inhibitors for HFpEF.

Fantastic session with Prof. Annemieke Madder (UGent) presenting an excellent perspective on the power of large peptides and “gigantic” bioconjugates in targeted therapy.

Great keynote by Prof. Paolo Melchiorre (University of Bologna) on The Synergy of Light, Organocatalysis & Enzymes.

First talk of the day: Prof. Helma Wennemers (ETH Zurich) on Asymmetric Peptide Catalysis.